Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXB2
|
ENSG00000173917.9 | homeobox B2 |
UNCX
|
ENSG00000164853.8 | UNC homeobox |
HOXD3
|
ENSG00000128652.7 | homeobox D3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_46623411_46623562 | HOXB2 | 45 | 0.876799 | 0.75 | 2.0e-02 | Click! |
chr17_46623160_46623411 | HOXB2 | 156 | 0.729302 | 0.19 | 6.2e-01 | Click! |
chr2_177025574_177025725 | HOXD3 | 30 | 0.941013 | -0.80 | 9.6e-03 | Click! |
chr2_177022201_177022391 | HOXD3 | 3323 | 0.102389 | 0.57 | 1.1e-01 | Click! |
chr2_177024576_177024903 | HOXD3 | 880 | 0.353887 | -0.46 | 2.1e-01 | Click! |
chr2_177000480_177000695 | HOXD3 | 1098 | 0.218404 | 0.42 | 2.6e-01 | Click! |
chr2_177025173_177025324 | HOXD3 | 371 | 0.705917 | -0.39 | 3.0e-01 | Click! |
chr7_1277542_1277732 | UNCX | 5094 | 0.233195 | 0.74 | 2.2e-02 | Click! |
chr7_1275593_1275744 | UNCX | 3125 | 0.273599 | -0.72 | 2.8e-02 | Click! |
chr7_1237809_1237960 | UNCX | 34659 | 0.118903 | -0.61 | 7.9e-02 | Click! |
chr7_1280480_1280631 | UNCX | 8012 | 0.216933 | 0.47 | 2.0e-01 | Click! |
chr7_1268185_1268336 | UNCX | 4283 | 0.235313 | 0.46 | 2.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_114633518_114633816 | 2.08 |
ACTR3 |
ARP3 actin-related protein 3 homolog (yeast) |
13870 |
0.21 |
chr4_78721201_78721381 | 1.68 |
CNOT6L |
CCR4-NOT transcription complex, subunit 6-like |
18926 |
0.25 |
chr12_68530648_68530810 | 1.67 |
IFNG |
interferon, gamma |
22798 |
0.24 |
chr7_6298731_6299016 | 1.65 |
CYTH3 |
cytohesin 3 |
13402 |
0.18 |
chrX_11784442_11784722 | 1.61 |
MSL3 |
male-specific lethal 3 homolog (Drosophila) |
6835 |
0.32 |
chr11_128173540_128173801 | 1.44 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
201619 |
0.03 |
chr10_6586306_6586575 | 1.39 |
PRKCQ |
protein kinase C, theta |
35761 |
0.23 |
chr17_33865226_33865568 | 1.38 |
SLFN12L |
schlafen family member 12-like |
517 |
0.66 |
chr9_20496246_20496647 | 1.34 |
ENSG00000264941 |
. |
5894 |
0.25 |
chr1_20015723_20015939 | 1.34 |
HTR6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
24051 |
0.16 |
chr19_9976591_9976870 | 1.34 |
OLFM2 |
olfactomedin 2 |
7886 |
0.11 |
chr7_138731189_138731354 | 1.33 |
ZC3HAV1L |
zinc finger CCCH-type, antiviral 1-like |
10496 |
0.21 |
chr20_57723034_57723340 | 1.32 |
ZNF831 |
zinc finger protein 831 |
42888 |
0.16 |
chr14_98641364_98641616 | 1.31 |
ENSG00000222066 |
. |
156597 |
0.04 |
chr6_112069279_112069430 | 1.31 |
FYN |
FYN oncogene related to SRC, FGR, YES |
10963 |
0.26 |
chr1_25969522_25969744 | 1.30 |
RP1-187B23.1 |
|
15969 |
0.18 |
chr10_17548800_17549076 | 1.29 |
ST8SIA6 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 |
52609 |
0.13 |
chr3_107697281_107697722 | 1.28 |
CD47 |
CD47 molecule |
79707 |
0.11 |
chr10_8130727_8131157 | 1.26 |
GATA3 |
GATA binding protein 3 |
34173 |
0.24 |
chr5_156964538_156964689 | 1.25 |
AC106801.1 |
|
28359 |
0.13 |
chr1_101746005_101746240 | 1.24 |
RP4-575N6.5 |
|
37408 |
0.14 |
chr2_205942725_205942950 | 1.22 |
PARD3B |
par-3 family cell polarity regulator beta |
532114 |
0.0 |
chr19_47948776_47948927 | 1.21 |
MEIS3 |
Meis homeobox 3 |
26071 |
0.11 |
chr2_204726088_204726239 | 1.20 |
CTLA4 |
cytotoxic T-lymphocyte-associated protein 4 |
6346 |
0.27 |
chrX_149646217_149646416 | 1.19 |
MAMLD1 |
mastermind-like domain containing 1 |
7036 |
0.24 |
chr21_43843966_43844673 | 1.19 |
ENSG00000252619 |
. |
6617 |
0.14 |
chr2_38816635_38816786 | 1.18 |
HNRNPLL |
heterogeneous nuclear ribonucleoprotein L-like |
10458 |
0.2 |
chr3_114044957_114045108 | 1.18 |
ENSG00000207770 |
. |
9616 |
0.18 |
chr2_204586779_204587049 | 1.17 |
CD28 |
CD28 molecule |
15498 |
0.22 |
chr10_11155205_11156000 | 1.17 |
CELF2-AS2 |
CELF2 antisense RNA 2 |
15166 |
0.21 |
chr18_56326276_56326514 | 1.14 |
MALT1 |
mucosa associated lymphoid tissue lymphoma translocation gene 1 |
12223 |
0.14 |
chr2_171508638_171509172 | 1.14 |
AC007277.3 |
|
8451 |
0.23 |
chr4_39035740_39035891 | 1.14 |
TMEM156 |
transmembrane protein 156 |
1273 |
0.48 |
chr1_111439380_111439531 | 1.14 |
CD53 |
CD53 molecule |
23679 |
0.15 |
chr1_117352258_117352539 | 1.12 |
CD2 |
CD2 molecule |
55309 |
0.12 |
chr5_98363313_98363584 | 1.11 |
ENSG00000200351 |
. |
90997 |
0.09 |
chr10_124175104_124175255 | 1.10 |
ENSG00000265442 |
. |
1302 |
0.43 |
chr3_196150607_196150758 | 1.10 |
UBXN7-AS1 |
UBXN7 antisense RNA 1 |
7553 |
0.11 |
chr1_179269438_179269674 | 1.10 |
SOAT1 |
sterol O-acyltransferase 1 |
6101 |
0.22 |
chr5_98259953_98260157 | 1.09 |
CHD1 |
chromodomain helicase DNA binding protein 1 |
2185 |
0.33 |
chr15_76578114_76578265 | 1.09 |
ETFA |
electron-transfer-flavoprotein, alpha polypeptide |
6643 |
0.24 |
chr17_71720142_71720293 | 1.09 |
SDK2 |
sidekick cell adhesion molecule 2 |
79989 |
0.1 |
chr20_35563459_35563616 | 1.09 |
SAMHD1 |
SAM domain and HD domain 1 |
16574 |
0.19 |
chr1_93445938_93446179 | 1.08 |
ENSG00000238787 |
. |
1807 |
0.23 |
chr3_177662574_177662851 | 1.06 |
ENSG00000199858 |
. |
62855 |
0.16 |
chr13_46893880_46894070 | 1.06 |
ENSG00000223336 |
. |
54750 |
0.1 |
chr12_838464_838718 | 1.05 |
WNK1 |
WNK lysine deficient protein kinase 1 |
23168 |
0.18 |
chr2_99279276_99279650 | 1.05 |
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
473 |
0.84 |
chr17_37970513_37970744 | 1.05 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
36150 |
0.11 |
chr8_121745821_121745972 | 1.05 |
RP11-713M15.1 |
|
27597 |
0.22 |
chr8_126941263_126941691 | 1.05 |
ENSG00000206695 |
. |
28282 |
0.26 |
chr14_75982573_75982735 | 1.05 |
BATF |
basic leucine zipper transcription factor, ATF-like |
6114 |
0.21 |
chr6_11276274_11276599 | 1.04 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
43521 |
0.17 |
chr3_33095798_33096165 | 1.04 |
GLB1 |
galactosidase, beta 1 |
42303 |
0.12 |
chr11_128167606_128167864 | 1.03 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
207554 |
0.02 |
chr2_58135745_58135896 | 1.03 |
VRK2 |
vaccinia related kinase 2 |
1034 |
0.7 |
chr6_16132777_16133009 | 1.02 |
MYLIP |
myosin regulatory light chain interacting protein |
3491 |
0.22 |
chr2_44901800_44902050 | 1.02 |
ENSG00000252896 |
. |
107344 |
0.07 |
chr8_124099579_124099969 | 1.02 |
TBC1D31 |
TBC1 domain family, member 31 |
6127 |
0.18 |
chr19_14461542_14461693 | 1.02 |
CD97 |
CD97 molecule |
30351 |
0.13 |
chr2_30557961_30558163 | 1.01 |
ENSG00000221377 |
. |
97252 |
0.07 |
chr21_34559932_34560083 | 1.01 |
C21orf54 |
chromosome 21 open reading frame 54 |
17466 |
0.15 |
chr7_150381782_150381933 | 1.01 |
GIMAP2 |
GTPase, IMAP family member 2 |
931 |
0.55 |
chr8_81052414_81052581 | 1.01 |
RP11-92K15.1 |
|
17410 |
0.19 |
chr8_90802794_90803092 | 1.01 |
RIPK2 |
receptor-interacting serine-threonine kinase 2 |
32881 |
0.22 |
chr14_61833316_61833710 | 1.00 |
PRKCH |
protein kinase C, eta |
5721 |
0.25 |
chr18_21549060_21549211 | 1.00 |
LAMA3 |
laminin, alpha 3 |
19278 |
0.17 |
chr18_60818297_60818519 | 0.99 |
RP11-299P2.1 |
|
145 |
0.97 |
chr1_101394347_101394839 | 0.99 |
SLC30A7 |
solute carrier family 30 (zinc transporter), member 7 |
32783 |
0.12 |
chrX_135818033_135818184 | 0.99 |
ARHGEF6 |
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
31394 |
0.15 |
chr13_42969980_42970150 | 0.98 |
AKAP11 |
A kinase (PRKA) anchor protein 11 |
123776 |
0.06 |
chr16_74620197_74620348 | 0.98 |
GLG1 |
golgi glycoprotein 1 |
20720 |
0.2 |
chr8_8731469_8731701 | 0.98 |
MFHAS1 |
malignant fibrous histiocytoma amplified sequence 1 |
19570 |
0.19 |
chr12_9104675_9104919 | 0.98 |
KLRG1 |
killer cell lectin-like receptor subfamily G, member 1 |
2157 |
0.23 |
chr2_106375349_106375537 | 0.98 |
NCK2 |
NCK adaptor protein 2 |
13255 |
0.28 |
chr5_100190438_100190674 | 0.97 |
ENSG00000221263 |
. |
38287 |
0.19 |
chr6_70525704_70525879 | 0.96 |
LMBRD1 |
LMBR1 domain containing 1 |
18788 |
0.25 |
chr7_50462451_50462702 | 0.96 |
ENSG00000200815 |
. |
40502 |
0.17 |
chr3_45912149_45912327 | 0.95 |
CCR9 |
chemokine (C-C motif) receptor 9 |
15758 |
0.16 |
chr2_204604427_204604578 | 0.94 |
ENSG00000211573 |
. |
25019 |
0.18 |
chr2_26018726_26019025 | 0.94 |
ASXL2 |
additional sex combs like 2 (Drosophila) |
15697 |
0.23 |
chr2_32036582_32036828 | 0.94 |
ENSG00000238448 |
. |
1348 |
0.49 |
chr14_99726122_99726406 | 0.94 |
AL109767.1 |
|
3021 |
0.29 |
chr3_32998308_32998459 | 0.94 |
CCR4 |
chemokine (C-C motif) receptor 4 |
5317 |
0.28 |
chr13_32616590_32616779 | 0.93 |
FRY-AS1 |
FRY antisense RNA 1 |
10908 |
0.22 |
chr3_195271784_195272156 | 0.93 |
AC091633.3 |
|
1099 |
0.4 |
chr10_33375837_33376051 | 0.93 |
ENSG00000263576 |
. |
11620 |
0.23 |
chr10_92962405_92962639 | 0.93 |
PCGF5 |
polycomb group ring finger 5 |
17386 |
0.29 |
chr5_95150906_95151226 | 0.93 |
GLRX |
glutaredoxin (thioltransferase) |
7349 |
0.16 |
chr10_82288993_82289258 | 0.92 |
RP11-137H2.4 |
|
6573 |
0.22 |
chr5_159900570_159900826 | 0.92 |
ENSG00000265237 |
. |
711 |
0.65 |
chr14_99694477_99694640 | 0.92 |
AL109767.1 |
|
34727 |
0.17 |
chr10_64288588_64288829 | 0.92 |
ZNF365 |
zinc finger protein 365 |
8501 |
0.3 |
chr15_91862101_91862471 | 0.92 |
SV2B |
synaptic vesicle glycoprotein 2B |
93186 |
0.09 |
chr2_225897633_225897784 | 0.91 |
DOCK10 |
dedicator of cytokinesis 10 |
9451 |
0.26 |
chr10_22903290_22903554 | 0.91 |
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
22780 |
0.26 |
chr9_92067897_92068161 | 0.91 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
2839 |
0.33 |
chr6_14276556_14277009 | 0.91 |
ENSG00000238987 |
. |
120089 |
0.06 |
chr3_98619464_98619615 | 0.90 |
DCBLD2 |
discoidin, CUB and LCCL domain containing 2 |
476 |
0.75 |
chr8_37132456_37132991 | 0.90 |
RP11-150O12.6 |
|
241816 |
0.02 |
chr8_127567681_127568033 | 0.90 |
RP11-103H7.5 |
|
1284 |
0.38 |
chr16_384366_384517 | 0.89 |
AXIN1 |
axin 1 |
18008 |
0.1 |
chr7_130762233_130762492 | 0.89 |
LINC-PINT |
long intergenic non-protein coding RNA, p53 induced transcript |
10871 |
0.21 |
chr2_144012089_144012556 | 0.89 |
RP11-190J23.1 |
|
82581 |
0.1 |
chr10_69648315_69648466 | 0.89 |
SIRT1 |
sirtuin 1 |
2852 |
0.28 |
chr5_110086965_110087116 | 0.88 |
SLC25A46 |
solute carrier family 25, member 46 |
3780 |
0.27 |
chr18_9121237_9121498 | 0.88 |
RP11-143J12.3 |
|
5492 |
0.17 |
chr19_24222899_24223050 | 0.88 |
ZNF254 |
zinc finger protein 254 |
6698 |
0.24 |
chr6_158677695_158677913 | 0.88 |
TULP4 |
tubby like protein 4 |
55888 |
0.12 |
chr1_167455057_167455208 | 0.88 |
RP11-104L21.2 |
|
27234 |
0.17 |
chr12_66788011_66788363 | 0.88 |
ENSG00000238528 |
. |
48688 |
0.15 |
chr1_193448919_193449104 | 0.88 |
ENSG00000252241 |
. |
252063 |
0.02 |
chr6_154561193_154561344 | 0.87 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
6722 |
0.33 |
chr2_144012636_144012869 | 0.87 |
RP11-190J23.1 |
|
83011 |
0.1 |
chr6_130537041_130537253 | 0.87 |
SAMD3 |
sterile alpha motif domain containing 3 |
68 |
0.98 |
chr14_98871416_98871598 | 0.87 |
ENSG00000241757 |
. |
53506 |
0.16 |
chr11_82831465_82831616 | 0.87 |
PCF11 |
PCF11 cleavage and polyadenylation factor subunit |
36490 |
0.13 |
chr12_68382310_68382485 | 0.87 |
IFNG-AS1 |
IFNG antisense RNA 1 |
828 |
0.76 |
chr2_198142561_198142937 | 0.87 |
ANKRD44-IT1 |
ANKRD44 intronic transcript 1 (non-protein coding) |
24494 |
0.15 |
chr9_98649500_98649877 | 0.86 |
ERCC6L2 |
excision repair cross-complementing rodent repair deficiency, complementation group 6-like 2 |
11705 |
0.19 |
chr7_37379203_37379459 | 0.86 |
ELMO1 |
engulfment and cell motility 1 |
3036 |
0.28 |
chr2_54808874_54809025 | 0.86 |
SPTBN1 |
spectrin, beta, non-erythrocytic 1 |
23418 |
0.17 |
chr8_126934068_126934219 | 0.86 |
ENSG00000206695 |
. |
20948 |
0.29 |
chr15_70554588_70554739 | 0.86 |
ENSG00000200216 |
. |
69088 |
0.13 |
chr2_143904317_143904751 | 0.86 |
ARHGAP15 |
Rho GTPase activating protein 15 |
17651 |
0.23 |
chr2_134940695_134940917 | 0.86 |
ENSG00000222921 |
. |
47960 |
0.15 |
chr2_69856813_69856964 | 0.86 |
AAK1 |
AP2 associated kinase 1 |
13898 |
0.21 |
chr3_98273092_98273322 | 0.86 |
GPR15 |
G protein-coupled receptor 15 |
22464 |
0.13 |
chr6_130833278_130833537 | 0.85 |
ENSG00000202438 |
. |
61850 |
0.12 |
chr13_97861790_97862048 | 0.85 |
MBNL2 |
muscleblind-like splicing regulator 2 |
11769 |
0.29 |
chr1_101548668_101549086 | 0.85 |
RP11-421L21.3 |
|
10661 |
0.19 |
chr4_122110651_122110802 | 0.85 |
ENSG00000252183 |
. |
3332 |
0.29 |
chr15_57329968_57330190 | 0.85 |
ENSG00000222586 |
. |
71484 |
0.12 |
chr17_1773103_1773254 | 0.85 |
RPA1 |
replication protein A1, 70kDa |
9151 |
0.15 |
chr11_121198510_121198941 | 0.85 |
SC5D |
sterol-C5-desaturase |
35164 |
0.22 |
chr1_111212434_111212585 | 0.85 |
KCNA3 |
potassium voltage-gated channel, shaker-related subfamily, member 3 |
5146 |
0.2 |
chr18_2976679_2976953 | 0.85 |
LPIN2 |
lipin 2 |
6055 |
0.16 |
chr10_27082496_27082647 | 0.84 |
ENSG00000206605 |
. |
2996 |
0.24 |
chr19_8813606_8813968 | 0.84 |
ACTL9 |
actin-like 9 |
4615 |
0.22 |
chr7_50203640_50204043 | 0.84 |
AC020743.2 |
|
21422 |
0.21 |
chr6_143211195_143211346 | 0.84 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
53086 |
0.16 |
chr4_78749172_78749323 | 0.84 |
CNOT6L |
CCR4-NOT transcription complex, subunit 6-like |
8478 |
0.26 |
chr8_129566610_129566901 | 0.84 |
ENSG00000221351 |
. |
265285 |
0.02 |
chr20_51025367_51025552 | 0.84 |
ZFP64 |
ZFP64 zinc finger protein |
216934 |
0.02 |
chr15_22452071_22452222 | 0.84 |
IGHV1OR15-1 |
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
3327 |
0.16 |
chr5_61873952_61874158 | 0.84 |
LRRC70 |
leucine rich repeat containing 70 |
507 |
0.52 |
chr2_204583285_204583561 | 0.84 |
CD28 |
CD28 molecule |
12007 |
0.23 |
chr1_167435126_167435452 | 0.84 |
RP11-104L21.2 |
|
7391 |
0.22 |
chr10_4015624_4015927 | 0.84 |
KLF6 |
Kruppel-like factor 6 |
188302 |
0.03 |
chr10_64515756_64515907 | 0.83 |
ADO |
2-aminoethanethiol (cysteamine) dioxygenase |
48685 |
0.13 |
chr3_56924360_56924511 | 0.83 |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
26064 |
0.21 |
chr10_116299670_116299821 | 0.83 |
ABLIM1 |
actin binding LIM protein 1 |
13055 |
0.27 |
chr11_128168491_128168694 | 0.83 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
206697 |
0.03 |
chr2_162055511_162055662 | 0.83 |
TANK |
TRAF family member-associated NFKB activator |
19454 |
0.2 |
chr5_110569357_110569585 | 0.83 |
CAMK4 |
calcium/calmodulin-dependent protein kinase IV |
9687 |
0.23 |
chr2_205745514_205745665 | 0.83 |
PARD3B |
par-3 family cell polarity regulator beta |
334866 |
0.01 |
chr17_47825562_47826034 | 0.82 |
FAM117A |
family with sequence similarity 117, member A |
15695 |
0.14 |
chr18_2976154_2976429 | 0.82 |
LPIN2 |
lipin 2 |
6580 |
0.16 |
chr5_61874985_61875174 | 0.82 |
LRRC70 |
leucine rich repeat containing 70 |
377 |
0.53 |
chr7_138757554_138757775 | 0.82 |
ZC3HAV1 |
zinc finger CCCH-type, antiviral 1 |
6349 |
0.22 |
chr14_61802522_61802673 | 0.82 |
PRKCH |
protein kinase C, eta |
8363 |
0.2 |
chr22_31704035_31704186 | 0.82 |
ENSG00000212542 |
. |
2720 |
0.17 |
chr14_102341333_102342059 | 0.82 |
PPP2R5C |
protein phosphatase 2, regulatory subunit B', gamma |
8178 |
0.19 |
chr21_26937814_26938070 | 0.81 |
ENSG00000234883 |
. |
8350 |
0.19 |
chr15_60850340_60850622 | 0.81 |
CTD-2501E16.2 |
|
28309 |
0.16 |
chr15_52802125_52802276 | 0.81 |
MYO5A |
myosin VA (heavy chain 12, myoxin) |
18838 |
0.2 |
chr7_50461192_50461505 | 0.81 |
ENSG00000200815 |
. |
41730 |
0.16 |
chr15_64804332_64804483 | 0.81 |
ZNF609 |
zinc finger protein 609 |
12916 |
0.16 |
chr19_13951569_13952139 | 0.81 |
ENSG00000207980 |
. |
4381 |
0.09 |
chr3_43064995_43065183 | 0.81 |
FAM198A |
family with sequence similarity 198, member A |
44049 |
0.13 |
chr10_4023787_4024265 | 0.81 |
KLF6 |
Kruppel-like factor 6 |
196553 |
0.03 |
chr12_9855485_9855919 | 0.81 |
CLEC2D |
C-type lectin domain family 2, member D |
15205 |
0.13 |
chr2_177716964_177717184 | 0.81 |
ENSG00000206866 |
. |
77744 |
0.11 |
chr10_6087007_6087203 | 0.81 |
IL2RA |
interleukin 2 receptor, alpha |
17148 |
0.13 |
chr8_19375495_19375646 | 0.81 |
CSGALNACT1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
83806 |
0.11 |
chr3_59997046_59997753 | 0.81 |
NPCDR1 |
nasopharyngeal carcinoma, down-regulated 1 |
39816 |
0.23 |
chr12_68512434_68512883 | 0.81 |
IFNG |
interferon, gamma |
40869 |
0.19 |
chr12_110905518_110905672 | 0.80 |
GPN3 |
GPN-loop GTPase 3 |
474 |
0.49 |
chr7_77564825_77565085 | 0.80 |
ENSG00000222432 |
. |
39758 |
0.17 |
chr7_21474691_21474842 | 0.80 |
SP4 |
Sp4 transcription factor |
7105 |
0.2 |
chr9_31336901_31337115 | 0.80 |
ENSG00000211510 |
. |
562782 |
0.0 |
chr7_104850801_104851099 | 0.80 |
SRPK2 |
SRSF protein kinase 2 |
58512 |
0.12 |
chrX_13023409_13023615 | 0.80 |
TMSB4X |
thymosin beta 4, X-linked |
29735 |
0.18 |
chr2_109581254_109581575 | 0.80 |
EDAR |
ectodysplasin A receptor |
24311 |
0.24 |
chr1_91189003_91189320 | 0.80 |
BARHL2 |
BarH-like homeobox 2 |
6367 |
0.31 |
chr4_84134465_84134616 | 0.79 |
COQ2 |
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
71378 |
0.1 |
chr6_151717255_151717406 | 0.79 |
ZBTB2 |
zinc finger and BTB domain containing 2 |
4647 |
0.17 |
chr6_149829598_149829769 | 0.79 |
ENSG00000252244 |
. |
8409 |
0.14 |
chr4_123541028_123541179 | 0.79 |
IL21-AS1 |
IL21 antisense RNA 1 |
965 |
0.45 |
chr1_29291606_29291930 | 0.79 |
ENSG00000206704 |
. |
20454 |
0.19 |
chr3_71410761_71410912 | 0.79 |
FOXP1 |
forkhead box P1 |
56925 |
0.15 |
chr17_54916742_54916893 | 0.79 |
DGKE |
diacylglycerol kinase, epsilon 64kDa |
4490 |
0.17 |
chr13_46775894_46776411 | 0.79 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
9331 |
0.15 |
chr3_112040032_112040183 | 0.79 |
CD200 |
CD200 molecule |
11087 |
0.23 |
chr5_130884180_130884409 | 0.79 |
RAPGEF6 |
Rap guanine nucleotide exchange factor (GEF) 6 |
15568 |
0.28 |
chr15_45014565_45014774 | 0.79 |
TRIM69 |
tripartite motif containing 69 |
6517 |
0.15 |
chr20_16689392_16689732 | 0.79 |
SNRPB2 |
small nuclear ribonucleoprotein polypeptide B |
21044 |
0.17 |
chr2_65260459_65260738 | 0.79 |
AC007386.4 |
|
4033 |
0.2 |
chr1_19933625_19933816 | 0.79 |
MINOS1-NBL1 |
MINOS1-NBL1 readthrough |
10159 |
0.13 |
chr9_92035198_92035541 | 0.79 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
1621 |
0.47 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 4.7 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.1 | 1.1 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
1.1 | 4.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.0 | 3.9 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.9 | 2.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.9 | 3.6 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.8 | 0.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.7 | 2.2 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.7 | 2.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.7 | 4.9 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.7 | 2.1 | GO:1901985 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.7 | 2.8 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.7 | 1.3 | GO:0034393 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.7 | 5.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.7 | 1.3 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.6 | 1.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.6 | 1.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.5 | 2.1 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.5 | 2.1 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.5 | 1.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.5 | 1.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.5 | 0.5 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.5 | 2.0 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.5 | 3.4 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.5 | 3.8 | GO:0002834 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.5 | 2.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 3.8 | GO:0007172 | signal complex assembly(GO:0007172) |
0.5 | 2.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.5 | 2.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.5 | 1.4 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.5 | 2.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.5 | 1.4 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.4 | 1.3 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.4 | 3.4 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.4 | 1.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.4 | 0.8 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.4 | 1.2 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.4 | 0.8 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.4 | 3.4 | GO:0043368 | positive T cell selection(GO:0043368) |
0.4 | 1.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.4 | 9.5 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.4 | 0.7 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.4 | 1.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.4 | 2.6 | GO:0002063 | chondrocyte development(GO:0002063) |
0.4 | 0.7 | GO:0002507 | tolerance induction(GO:0002507) |
0.4 | 1.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.4 | 0.4 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) |
0.3 | 1.4 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.3 | 3.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.3 | 1.0 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.3 | 1.7 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.3 | 0.7 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.3 | 1.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 0.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 1.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.3 | 1.6 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.3 | 2.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.3 | 0.3 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.3 | 1.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 0.6 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.3 | 0.9 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 2.4 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.3 | 0.9 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.3 | 1.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 0.8 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 1.4 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.3 | 1.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 14.5 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.3 | 0.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.3 | 0.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 0.3 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.3 | 1.3 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.3 | 1.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 0.5 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.3 | 1.3 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.3 | 0.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.3 | 0.5 | GO:0033084 | immature T cell proliferation(GO:0033079) regulation of immature T cell proliferation(GO:0033083) regulation of immature T cell proliferation in thymus(GO:0033084) |
0.3 | 0.8 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.3 | 2.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.3 | 0.5 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.3 | 0.5 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.2 | 0.7 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.5 | GO:1904376 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 1.7 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.7 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 0.9 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.7 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.4 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.7 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.2 | 0.7 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 4.0 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.2 | 0.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 0.6 | GO:0032506 | cytokinetic process(GO:0032506) |
0.2 | 0.4 | GO:0034776 | response to histamine(GO:0034776) |
0.2 | 3.4 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.2 | 0.4 | GO:0051283 | release of sequestered calcium ion into cytosol(GO:0051209) regulation of sequestering of calcium ion(GO:0051282) negative regulation of sequestering of calcium ion(GO:0051283) calcium ion transmembrane import into cytosol(GO:0097553) calcium ion import into cytosol(GO:1902656) |
0.2 | 0.2 | GO:0016233 | telomere capping(GO:0016233) protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.2 | 1.2 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.2 | 1.0 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.2 | 1.0 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.2 | 1.4 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.2 | 0.2 | GO:0017085 | response to insecticide(GO:0017085) |
0.2 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 0.4 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 1.8 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.2 | 0.2 | GO:0051208 | sequestering of calcium ion(GO:0051208) |
0.2 | 0.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.6 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 0.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.4 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.6 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.2 | 0.6 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 0.4 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.2 | 0.6 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.2 | 0.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 2.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.5 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.2 | 0.5 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.5 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 0.5 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.2 | 0.7 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.2 | 1.3 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 0.2 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) transcription factor import into nucleus(GO:0042991) |
0.2 | 0.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 0.3 | GO:0035710 | CD4-positive, alpha-beta T cell activation(GO:0035710) |
0.2 | 0.5 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.2 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 1.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 0.5 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.2 | 1.2 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.2 | 0.3 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.2 | 0.2 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.2 | 0.7 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 2.1 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.2 | 0.3 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.2 | 0.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.5 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 0.8 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.2 | 0.5 | GO:2001234 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.2 | 0.8 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 1.4 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 1.1 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.2 | 0.9 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 0.2 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.2 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.3 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.2 | 0.8 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.2 | 0.3 | GO:0051608 | histamine secretion(GO:0001821) histamine transport(GO:0051608) |
0.2 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.6 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 0.2 | GO:0031223 | auditory behavior(GO:0031223) |
0.2 | 3.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 0.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.6 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.6 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.3 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.7 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 1.9 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.6 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.3 | GO:0032825 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 1.1 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.6 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.4 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 1.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.4 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.1 | 0.6 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.5 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 1.9 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0045359 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 0.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.3 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.3 | GO:0071801 | regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.7 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 3.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.9 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.4 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.1 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.5 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0060510 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.1 | GO:0070265 | necrotic cell death(GO:0070265) |
0.1 | 0.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.4 | GO:0001711 | endodermal cell fate commitment(GO:0001711) endodermal cell differentiation(GO:0035987) |
0.1 | 0.1 | GO:2000279 | negative regulation of telomerase activity(GO:0051974) negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.6 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.2 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.5 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 1.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 1.0 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.6 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.5 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.1 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.3 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.2 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.1 | 0.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.7 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.9 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.4 | GO:0021604 | cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) |
0.1 | 0.1 | GO:0006323 | DNA packaging(GO:0006323) |
0.1 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.7 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 2.2 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 1.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.3 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.3 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.1 | 0.3 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0072273 | metanephric nephron morphogenesis(GO:0072273) |
0.1 | 1.1 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.2 | GO:0010536 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 0.2 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 2.2 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.1 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 2.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.5 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.5 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.5 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.1 | 0.6 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 1.6 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.4 | GO:0021684 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.3 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.1 | 1.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.6 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.7 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0071503 | response to heparin(GO:0071503) |
0.1 | 1.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.4 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.3 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.6 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.1 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.1 | 0.4 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 7.8 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 0.1 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.1 | 0.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.8 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.1 | GO:1904019 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.1 | 1.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 1.3 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.8 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.4 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.4 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 2.2 | GO:1904590 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of intracellular protein transport(GO:0090317) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) |
0.1 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.2 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 1.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.3 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.3 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.2 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.1 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.1 | 0.3 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.1 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.3 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.3 | GO:0000470 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.6 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.1 | GO:0072172 | mesonephric tubule formation(GO:0072172) |
0.1 | 1.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 3.3 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 1.1 | GO:0048255 | RNA stabilization(GO:0043489) mRNA stabilization(GO:0048255) |
0.1 | 0.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.2 | GO:2000257 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.1 | 0.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.2 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.1 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.3 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.8 | GO:0098657 | neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
0.1 | 1.0 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 0.8 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.2 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.7 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 0.4 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.1 | 0.3 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.4 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.2 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.8 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.5 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.7 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 0.4 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.1 | 0.4 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.1 | 0.2 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.1 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.1 | 0.2 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 1.0 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.1 | GO:0021561 | facial nerve development(GO:0021561) |
0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.2 | GO:0015853 | adenine transport(GO:0015853) |
0.1 | 0.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 1.1 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.1 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.3 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.1 | 0.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.5 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.9 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.1 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.1 | 0.4 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.1 | 0.7 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.3 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.1 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.1 | 0.1 | GO:1903828 | negative regulation of cellular protein localization(GO:1903828) |
0.1 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.2 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.4 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 1.5 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.2 | GO:1903504 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 3.1 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.5 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) regulation of neurotransmitter transport(GO:0051588) |
0.1 | 0.1 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.2 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.1 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.1 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 3.8 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.4 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.6 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.1 | 0.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 1.4 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 1.1 | GO:0021549 | cerebellum development(GO:0021549) |
0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.1 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.1 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.1 | GO:0070897 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.3 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.1 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.1 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
0.1 | 0.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.3 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.4 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 2.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.2 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.2 | GO:0071459 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.1 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 0.5 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.3 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.1 | 0.7 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.1 | 0.5 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.1 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.1 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.2 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 0.5 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.8 | GO:0016254 | C-terminal protein lipidation(GO:0006501) preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 0.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 1.4 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.2 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.2 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.1 | 0.1 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.1 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 1.5 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 2.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.1 | 0.1 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.1 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.2 | GO:0075733 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.1 | 1.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 11.8 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.1 | 0.2 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.2 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.1 | 0.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.1 | GO:0021819 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.4 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 0.4 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.1 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.1 | 0.1 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.1 | 2.0 | GO:0097194 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) execution phase of apoptosis(GO:0097194) |
0.1 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.3 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.5 | GO:0048265 | response to pain(GO:0048265) |
0.1 | 0.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.0 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 | 0.1 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.0 | 0.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.5 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.1 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.0 | 0.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.0 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.1 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.0 | 0.0 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.2 | GO:0021891 | olfactory bulb interneuron differentiation(GO:0021889) olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.0 | GO:0060968 | regulation of gene silencing(GO:0060968) |
0.0 | 0.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.3 | GO:0019226 | transmission of nerve impulse(GO:0019226) multicellular organismal signaling(GO:0035637) |
0.0 | 2.4 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.5 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.0 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.0 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.0 | 0.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 2.1 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.8 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.3 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.0 | GO:0090398 | cellular senescence(GO:0090398) |
0.0 | 0.1 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.2 | GO:1901998 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 1.1 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.2 | GO:1901224 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.3 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.0 | 0.8 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.5 | GO:0043574 | peroxisomal transport(GO:0043574) |
0.0 | 0.1 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.0 | GO:0021778 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.0 | 0.2 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.0 | 0.7 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.0 | GO:0002251 | innate immune response in mucosa(GO:0002227) organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.0 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 1.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.6 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.1 | GO:0015825 | L-serine transport(GO:0015825) alanine transport(GO:0032328) |
0.0 | 0.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.0 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 1.0 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.1 | GO:0070723 | response to sterol(GO:0036314) response to cholesterol(GO:0070723) |
0.0 | 0.2 | GO:0045843 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle organ development(GO:0048635) negative regulation of muscle tissue development(GO:1901862) |
0.0 | 0.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.2 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.0 | 1.2 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:0003143 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.0 | 0.1 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.3 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.0 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.0 | 0.3 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.0 | 0.2 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.0 | 0.6 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.1 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.0 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.0 | 0.9 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.1 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.1 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.4 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.0 | 0.1 | GO:0046477 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0072207 | metanephric tubule development(GO:0072170) metanephric epithelium development(GO:0072207) metanephric nephron tubule development(GO:0072234) metanephric nephron epithelium development(GO:0072243) |
0.0 | 0.1 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.2 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.0 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.0 | 0.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.0 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 0.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.0 | GO:0016198 | axon choice point recognition(GO:0016198) axon midline choice point recognition(GO:0016199) |
0.0 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.2 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.0 | 0.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.4 | GO:0030902 | hindbrain development(GO:0030902) |
0.0 | 0.3 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.0 | 3.0 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.2 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.2 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.1 | GO:0010954 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.0 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.1 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 8.9 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.0 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.2 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:0032401 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
0.0 | 0.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.0 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) anatomical structure regression(GO:0060033) |
0.0 | 0.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.0 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.0 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.1 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.1 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.0 | 0.0 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.2 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 2.5 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.1 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.0 | 0.0 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.4 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.5 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.0 | 0.1 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.0 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.0 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.0 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.0 | 0.0 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 0.2 | GO:0046849 | bone remodeling(GO:0046849) |
0.0 | 0.0 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.5 | GO:0042384 | cilium assembly(GO:0042384) |
0.0 | 0.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.0 | GO:0051445 | regulation of meiotic cell cycle(GO:0051445) |
0.0 | 0.0 | GO:0051647 | nucleus localization(GO:0051647) |
0.0 | 0.5 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.6 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.1 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 0.0 | GO:0072210 | metanephric nephron development(GO:0072210) |
0.0 | 0.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.1 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.2 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.0 | 0.0 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.0 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.0 | 0.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 2.0 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.1 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.0 | 0.0 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.0 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.0 | 0.1 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.0 | GO:0060251 | regulation of glial cell proliferation(GO:0060251) |
0.0 | 0.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.0 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:0045006 | DNA deamination(GO:0045006) |
0.0 | 1.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.0 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.0 | 0.1 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.0 | GO:0046543 | thelarche(GO:0042695) development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) mammary gland branching involved in thelarche(GO:0060744) |
0.0 | 0.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.0 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.0 | 0.0 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.0 | 0.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
0.0 | 0.1 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.1 | GO:0010821 | regulation of mitochondrion organization(GO:0010821) |
0.0 | 1.4 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.2 | GO:0045762 | positive regulation of cyclase activity(GO:0031281) positive regulation of adenylate cyclase activity(GO:0045762) |
0.0 | 0.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.2 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.1 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.3 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.0 | 0.2 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.0 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.0 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.2 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.0 | 0.2 | GO:0034765 | regulation of ion transmembrane transport(GO:0034765) |
0.0 | 0.1 | GO:0042596 | fear response(GO:0042596) |
0.0 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.0 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.0 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.4 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.0 | 0.1 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.0 | 0.0 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.0 | 0.0 | GO:1902808 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.0 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.0 | 0.0 | GO:0097028 | myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
0.0 | 0.0 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.1 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.0 | 0.0 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.0 | 0.0 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.0 | 0.0 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.0 | 0.0 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.0 | 0.0 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.1 | GO:0015813 | acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
0.0 | 0.1 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.0 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.1 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.0 | 0.0 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.0 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.0 | GO:0019730 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.0 | 0.0 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.1 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.0 | 0.0 | GO:0003097 | renal water transport(GO:0003097) |
0.0 | 0.0 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.0 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.7 | 0.7 | GO:0001740 | Barr body(GO:0001740) |
0.6 | 4.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 0.5 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.5 | 1.5 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 1.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 1.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.4 | 2.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 4.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 1.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 1.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 3.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 0.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.3 | 0.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 3.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 1.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 2.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 0.8 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.2 | 0.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.8 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 0.8 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 1.0 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 2.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 0.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.4 | GO:0019867 | outer membrane(GO:0019867) |
0.2 | 2.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 1.1 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 0.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 0.2 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.2 | 2.0 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 1.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 1.0 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.2 | 0.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 1.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 0.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 0.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.4 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.2 | 2.1 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 1.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.3 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.7 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.8 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 1.0 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 4.6 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.4 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 2.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 2.1 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 1.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 1.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 3.8 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 2.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.1 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 0.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 1.9 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 1.2 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.1 | 1.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 4.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.4 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 1.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.3 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.1 | 0.1 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 1.5 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.5 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 1.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.5 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 2.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 1.0 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.5 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 10.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.8 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 1.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 1.0 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 0.9 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.9 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.1 | 0.2 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.1 | 1.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 1.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 3.4 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.7 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 2.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.5 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.4 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 6.7 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 0.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 3.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 5.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.9 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 1.4 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.1 | 2.3 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.1 | GO:0031312 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of organelle membrane(GO:0031312) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 1.6 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 1.0 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.2 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.9 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.1 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 1.2 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.7 | GO:0030684 | preribosome(GO:0030684) |
0.1 | 0.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.2 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 4.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 2.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 1.5 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.3 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 2.4 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.9 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.1 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 0.2 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.1 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 1.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.8 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.2 | GO:0005903 | brush border(GO:0005903) |
0.0 | 31.1 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.0 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.0 | 0.1 | GO:0098573 | integral component of mitochondrial membrane(GO:0032592) intrinsic component of mitochondrial membrane(GO:0098573) |
0.0 | 0.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.0 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.5 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 5.0 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.2 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.0 | 0.9 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 1.7 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 1.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.3 | GO:0030313 | outer membrane-bounded periplasmic space(GO:0030288) cell envelope(GO:0030313) periplasmic space(GO:0042597) |
0.0 | 0.1 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.0 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.3 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.3 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.4 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 9.0 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.3 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.0 | 0.4 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.9 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 1.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 1.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.0 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 1.4 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 1.1 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.0 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 4.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 8.3 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 24.8 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 5.2 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 0.0 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.1 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.0 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 45.7 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.1 | GO:0035770 | ribonucleoprotein granule(GO:0035770) cytoplasmic ribonucleoprotein granule(GO:0036464) |
0.0 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.7 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 6.5 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.0 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.0 | 0.0 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.0 | 0.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 1.1 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 1.0 | GO:0070013 | intracellular organelle lumen(GO:0070013) |
0.0 | 0.0 | GO:0030008 | TRAPP complex(GO:0030008) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.9 | 2.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.8 | 2.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.7 | 2.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.6 | 9.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.5 | 3.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 1.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.5 | 4.5 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.5 | 1.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.5 | 1.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.5 | 1.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 1.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.4 | 1.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.4 | 1.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.4 | 1.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.4 | 0.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.4 | 3.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 1.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.4 | 1.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 2.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 1.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 7.5 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 4.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 1.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 2.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 1.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 1.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 2.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 1.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 0.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 1.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.3 | 0.8 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.3 | 0.8 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.3 | 0.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 0.8 | GO:0004875 | complement receptor activity(GO:0004875) |
0.3 | 3.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 3.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 0.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 1.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 0.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 5.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 2.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 3.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 1.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 1.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 1.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 1.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 1.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 2.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 0.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.6 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 0.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 0.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.2 | 0.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.6 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 10.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.4 | GO:0060229 | lipase activator activity(GO:0060229) |
0.2 | 1.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 1.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 0.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 1.5 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 2.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 2.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 0.4 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.2 | 0.9 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 1.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 1.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 4.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.5 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.2 | 6.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.5 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 1.4 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 0.2 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.2 | 1.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 1.4 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.2 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 0.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 0.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 0.5 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 1.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.2 | 1.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 1.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 2.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 1.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 1.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 1.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 5.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 1.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 1.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 1.4 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 0.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.4 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 4.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 2.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 2.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.5 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.4 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 2.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.7 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 6.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.6 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 0.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.1 | 0.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.6 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 4.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 1.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 2.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.4 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.1 | 2.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 1.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 2.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.6 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 1.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 1.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.4 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.1 | 2.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 3.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 3.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 1.4 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 2.9 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 5.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 3.1 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 0.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 1.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.9 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.6 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 2.4 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 1.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.1 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.1 | 1.6 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.5 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 0.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.6 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.1 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 1.0 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 1.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 1.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.3 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 2.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 1.4 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.1 | 0.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.2 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.1 | 1.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.7 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 0.2 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 1.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 1.0 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.1 | 0.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 1.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.8 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.8 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.3 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.3 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.4 | GO:0046969 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H3-K9 specific)(GO:0032129) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent protein deacetylase activity(GO:0034979) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.1 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 2.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 2.3 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.2 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.2 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.1 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 1.5 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.1 | 0.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.8 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.1 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 1.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.1 | GO:0051192 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.1 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.1 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.9 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.1 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) |
0.1 | 0.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.3 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.4 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 0.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.3 | GO:0061659 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 1.7 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.9 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 1.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 1.0 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 3.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 22.6 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.5 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 1.0 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.3 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.4 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.2 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.0 | 0.1 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.5 | GO:0005035 | death receptor activity(GO:0005035) |
0.0 | 0.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.5 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.7 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.4 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 1.5 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.2 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 1.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 1.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.0 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.0 | 0.3 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.9 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.2 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 5.8 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 8.6 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.8 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 1.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.1 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.2 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.1 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 2.4 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.1 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 0.2 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 41.7 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.5 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.2 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.1 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0080032 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.0 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.5 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.8 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 1.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.1 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 0.0 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.0 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.0 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.0 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.0 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.0 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.3 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.0 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.0 | GO:0004556 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.0 | 0.0 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 32.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.5 | 4.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 4.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 0.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 1.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 8.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 1.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 8.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 2.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 5.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 3.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 0.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 11.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 4.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 2.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 0.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 5.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 8.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 0.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 4.1 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 1.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 1.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 1.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 4.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 3.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 3.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 3.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 2.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 2.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 4.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 4.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 2.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 3.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 3.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 2.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 2.0 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.9 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.7 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 2.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.6 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 1.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 1.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.4 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.8 | 8.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.6 | 13.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 6.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.5 | 5.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.4 | 1.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 8.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 1.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 3.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 2.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 3.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 4.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 3.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 1.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 6.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 0.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 2.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 1.8 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.2 | 3.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 0.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 4.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 4.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 6.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 0.4 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.2 | 4.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 1.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 1.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 2.9 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 0.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 8.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 2.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 2.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 2.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.6 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 2.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 1.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.0 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 1.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 2.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 4.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 0.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 0.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.4 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 1.0 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.8 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.1 | 1.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 2.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.7 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 1.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 4.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.7 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
0.1 | 2.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.5 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 0.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 6.3 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.1 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 1.2 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 0.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 0.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 1.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.8 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 0.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 0.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 4.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.7 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 0.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 2.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 3.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 2.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.4 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.1 | 0.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 6.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 4.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 2.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 1.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 2.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 1.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.6 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 1.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.5 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 1.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.0 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.0 | 0.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.6 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 4.8 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.0 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |